tiprankstipranks
Trending News
More News >
Nemaura Medical Inc (NMRD)
OTHER OTC:NMRD
US Market

Nemaura Medical (NMRD) Price & Analysis

Compare
160 Followers

NMRD Stock Chart & Stats

$0.05
$0.00(0.00%)
At close: 4:00 PM EST
$0.05
$0.00(0.00%)

Nemaura Medical News

NMRD FAQ

What was Nemaura Medical Inc’s price range in the past 12 months?
Nemaura Medical Inc lowest stock price was $0.01 and its highest was $0.39 in the past 12 months.
    What is Nemaura Medical Inc’s market cap?
    Nemaura Medical Inc’s market cap is $40.00.
      When is Nemaura Medical Inc’s upcoming earnings report date?
      The company’s upcoming earnings report date is not yet available.
      How were Nemaura Medical Inc’s earnings last quarter?
      Currently, no data Available
      Is Nemaura Medical Inc overvalued?
      According to Wall Street analysts Nemaura Medical Inc’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
        Does Nemaura Medical Inc pay dividends?
        Nemaura Medical Inc does not currently pay dividends.
        What is Nemaura Medical Inc’s EPS estimate?
        Nemaura Medical Inc’s EPS estimate for its next earnings report is not yet available.
        How many shares outstanding does Nemaura Medical Inc have?
        Nemaura Medical Inc has 40,351,704 shares outstanding.
          What happened to Nemaura Medical Inc’s price movement after its last earnings report?
          Currently, no data Available
          Which hedge fund is a major shareholder of Nemaura Medical Inc?
          Currently, no hedge funds are holding shares in NMRD
          What is the TipRanks Smart Score and how is it calculated?
          Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

            Company Description

            Nemaura Medical Inc

            Nemaura Medical Inc., a medical technology company, discovers, develops, and commercializes diagnostic medical devices. It provides sugarBEAT, a non-invasive continuous glucose monitoring device for use by persons with Type I and Type II diabetes, as well as screen pre-diabetic patients. The company also offers proBEAT, a wellness guidance notes, that provide prompts and educate users on factors affecting blood sugar profiles, as well as conducts diabetes prevention and reversal programs. Nemaura Medical Inc. was founded in 2009 and is based in New York, New York.

            Nemaura Medical (NMRD) Earnings & Revenues

            Similar Stocks
            Company
            Price & Change
            Follow
            Dexcom
            Insulet
            Tandem Diabetes Care
            Xtant Medical Holdings
            Senseonics Holdings

            Ownership Overview

            2.09%97.91%
            Insiders
            Mutual Funds
            2.09% Other Institutional Investors
            97.91% Public Companies and
            Individual Investors

            Options Prices

            Currently, No data available
            ---
            Popular Stocks